Register Cart 0

Generic placeholder image

Current Molecular Pharmacology

Editor-in-Chief

ISSN (Print): 1874-4672
ISSN (Online): 1874-4702

Back Subscribe

Editorial

State of the Art Molecular Pharmacology, Pathogenesis and Epigenetics of 3 Major Cancers: Lung Cancer, Ovarian Cancer, and Gliomas

Author(s): Fotios Sampsonas

Volume 14, Issue 6, 2021

Article ID: e201221199181 Pages: 1

DOI: 10.2174/187446721406211220154432

TIMBC 2025

Rights & Permissions Print Cite

Article Metrics

15

Wayfinder Image

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

For Visitors

TIMBC 2025

Related Articles

Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas
Current Pharmaceutical Design

Intranasal Delivery of Perillyl Alcohol (NEO100) as a New Treatment Strategy for Glioma
Drug Delivery Letters

Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Current Pharmaceutical Design

Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy
Current Cancer Drug Targets

Biomarkers for Systemic Therapy in Ovarian Cancer
Current Cancer Drug Targets

The Yin and Yang of microRNA Assay Methods
MicroRNA

Neurocysticercosis: The Enigmatic Disease
Central Nervous System Agents in Medicinal Chemistry

CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry

Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism

Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively
CNS & Neurological Disorders - Drug Targets

Metabotropic Glutamate Receptors Type 3 and 5 Feature the “NeuroTransmitter-type” of Glioblastoma: A Bioinformatic Approach
Current Neuropharmacology

Natural compound-derived epigenetic regulators targeting epigenetic readers, writers and erasers
Current Topics in Medicinal Chemistry

Collateral Damage Control in Cancer Therapy: Defining the Stem Identity in Gliomas
Current Pharmaceutical Design

Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy
Anti-Cancer Agents in Medicinal Chemistry

Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology

The Mechanism of Action of Salsolinol in Brain: Implications in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets

Inducers of Heme Oxygenase-1
Current Pharmaceutical Design

Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway
Current Medicinal Chemistry

Tissue Biomarkers for Prostate Cancer Radiation Therapy
Current Molecular Medicine

Antiangiogenic Therapy in Malignant Glioma: Promise and Challenge
Current Pharmaceutical Design

© 2025 Bentham Science Publishers | Privacy Policy